Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (2886)
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
8,400
Price
$87.15
Total Value
$732.06K
Shares Held After
556,640
% of Holdings
1.5%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
900
Price
$86.25
Total Value
$77.62K
Shares Held After
104,594
% of Holdings
0.9%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,500
Price
$86.36
Total Value
$215.90K
Shares Held After
565,040
% of Holdings
0.4%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
29,088
Price
$7.06
Total Value
$205.36K
Shares Held After
4,202,346
% of Holdings
0.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
29,088
Price
$7.06
Total Value
$205.36K
Shares Held After
4,202,346
% of Holdings
0.7%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
584
Price
$14.00
Total Value
$8.18K
Shares Held After
8,617
% of Holdings
6.3%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
21,688
Price
$98.91
Total Value
$2.15M
Shares Held After
194,440
% of Holdings
10.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
8,312
Price
$98.08
Total Value
$815.24K
Shares Held After
216,128
% of Holdings
3.7%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
3,333
Price
$37.83
Total Value
$126.08K
Shares Held After
96,412
% of Holdings
3.3%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
132
Price
$355.86
Total Value
$46.97K
Shares Held After
0
% of Holdings
100.0%
Moderna, Inc. (MRNA)
Klinger Shannon Thyme — Chief Legal Officer
Shares
3,471
Price
$139.95
Total Value
$485.77K
Shares Held After
74,129
% of Holdings
4.5%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
16,141
Price
$26.36
Total Value
$425.51K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
13,309
Price
$106.74
Total Value
$1.42M
Shares Held After
4,000
% of Holdings
76.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
7,215
Price
$106.25
Total Value
$766.59K
Shares Held After
17,309
% of Holdings
29.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
2,600
Price
$105.19
Total Value
$273.49K
Shares Held After
24,524
% of Holdings
9.6%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
274
Price
$67.76
Total Value
$18.57K
Shares Held After
117,308
% of Holdings
0.2%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
1,600
Price
$31.06
Total Value
$49.69K
Shares Held After
20,110
% of Holdings
7.4%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
3,945
Price
$30.51
Total Value
$120.37K
Shares Held After
21,710
% of Holdings
15.4%
Denali Therapeutics Inc. (DNLI)
Schuth Alexander O. — COFO and Secretary
Shares
2,768
Price
$23.44
Total Value
$64.88K
Shares Held After
278,995
% of Holdings
1.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
783
Price
$69.52
Total Value
$54.43K
Shares Held After
526,000
% of Holdings
0.1%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
303
Price
$61.42
Total Value
$18.61K
Shares Held After
155,041
% of Holdings
0.2%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
924
Price
$60.95
Total Value
$56.32K
Shares Held After
155,344
% of Holdings
0.6%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
713
Price
$61.48
Total Value
$43.84K
Shares Held After
156,268
% of Holdings
0.5%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
1,537
Price
$60.89
Total Value
$93.58K
Shares Held After
156,981
% of Holdings
1.0%
AN2 Therapeutics, Inc. (ANTX)
FitzPatrick Margaret M — Director
Shares
2,098
Price
$5.53
Total Value
$11.60K
Shares Held After
10,708
% of Holdings
19.6%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
30,000
Price
$3.34
Total Value
$100.20K
Shares Held After
6,158,287
% of Holdings
0.5%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
179,058
Price
$1.80
Total Value
$321.57K
Shares Held After
5,436,447
% of Holdings
3.3%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
6,000
Price
$250.13
Total Value
$1.50M
Shares Held After
351,875
% of Holdings
1.7%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
19
Price
$2.02
Total Value
$38.38
Shares Held After
23,782
% of Holdings
0.1%
MediWound Ltd. (MDWD)
Rubinstein Samuel — Director
Shares
525
Price
$12.62
Total Value
$6.63K
Shares Held After
525
% of Holdings
100.0%
MediWound Ltd. (MDWD)
Rubinstein Samuel — Director
Shares
525
Price
$12.72
Total Value
$6.68K
Shares Held After
0
% of Holdings
100.0%
Orchestra BioMed Holdings, Inc. (OBIO)
Sherman Darren — Director
Shares
15,000
Price
$4.94
Total Value
$74.10K
Shares Held After
1,134,402
% of Holdings
1.3%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
9,000
Price
$46.99
Total Value
$422.87K
Shares Held After
65,389
% of Holdings
12.1%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
4,800
Price
$92.44
Total Value
$443.69K
Shares Held After
925,580
% of Holdings
0.5%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
63,596
Price
$91.90
Total Value
$5.84M
Shares Held After
930,380
% of Holdings
6.4%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
6,604
Price
$90.79
Total Value
$599.56K
Shares Held After
993,976
% of Holdings
0.7%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
4,000
Price
$92.01
Total Value
$368.05K
Shares Held After
236,384
% of Holdings
1.7%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
1,000
Price
$91.05
Total Value
$91.05K
Shares Held After
240,384
% of Holdings
0.4%
Xeris Biopharma Holdings, Inc. (XERS)
McCulloch Kevin — President and Chief Operating Officer
Shares
15,000
Price
$8.49
Total Value
$127.31K
Shares Held After
1,639,208
% of Holdings
0.9%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,666
Price
$8.49
Total Value
$141.43K
Shares Held After
1,127,796
% of Holdings
1.5%
Xeris Biopharma Holdings, Inc. (XERS)
Pieper Steven — Chief Financial Officer
Shares
5,000
Price
$8.50
Total Value
$42.50K
Shares Held After
1,356,053
% of Holdings
0.4%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
1,452
Price
$25.47
Total Value
$36.98K
Shares Held After
117,227
% of Holdings
1.2%
ABEONA THERAPEUTICS INC. (ABEO)
Alvino Mark — Director
Shares
15,000
Price
$5.86
Total Value
$87.97K
Shares Held After
62,065
% of Holdings
19.5%
CYTOKINETICS INC (CYTK)
PARSHALL B LYNNE — Director
Shares
5,000
Price
$71.48
Total Value
$357.40K
Shares Held After
10,784
% of Holdings
31.7%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Former Director
Shares
10,000
Price
$12.11
Total Value
$121.10K
Shares Held After
124,411
% of Holdings
7.4%
Helus Pharma Inc. (HELP)
Glavine Paul — Chief Growth Officer
Shares
90,000
Price
$11.59
Total Value
$1.04M
Shares Held After
4,071,252
% of Holdings
2.2%
ALTERITY THERAPEUTICS LTD (ATHE)
Marks Peter Ashley — Director
Shares
47,620
Price
$0.50
Total Value
$23.81K
Shares Held After
191,340
% of Holdings
24.9%
Camp4 Therapeutics Corp (CAMP)
Gold Kelly — Chief Financial Officer
Shares
10,000
Price
$3.96
Total Value
$39.60K
Shares Held After
10,000
% of Holdings
100.0%
GENELUX Corp (GNLX)
Yu Yong — Chief Scientific Officer
Shares
9,683
Price
$2.75
Total Value
$26.66K
Shares Held After
258,688
% of Holdings
3.6%
GENELUX Corp (GNLX)
Zindrick Thomas — President and CEO
Shares
34,463
Price
$2.67
Total Value
$91.90K
Shares Held After
1,226,427
% of Holdings
2.7%
Showing 1451–1500 of 2886 transactions (page 30 of 58)